Skip to main content
Premium Trial:

Request an Annual Quote

ZyGem, TATAA Ink Distribution Deal

NEW YORK (GenomeWeb News) – ZyGem today said it has entered into a non-exclusive distribution deal with Tataa Biocenter.

The deal is for the distribution of ZyGem's DNA and RNA extraction products in Sweden and other selected countries. Other details were not disclosed.

ZyGem's kits use a single-tube process to provide complete extraction of DNA and RNA from specific sample types. The firm said that the technology reduces time and cost of DNA and RNA extractions by simplifying laboratory workflow, minimizing error and the risk of contamination, ensuring sample integrity, and facilitating extractions from trace samples.

The Charlottesville, Va.-based company inked an original equipment deal with Saudi Diagnostics earlier this year for its DNA and RNA extraction kits.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.